Embryo Selection by Noninvasive Preimplantation Genetic Test

Key facts

Sponsor

Peking University Third Hospital

Principal Investigator

Jie Qiao

Peking University Third Hospital

Intervention

Non-invasive chromosome screening（NICS）(diagnostic_test)

Enrollment

1152 target

Eligibility

35-42 years · FEMALE

Timeline

2020 – 2024

Study locations (13)

• The First Affiliated Hospital,Sun Yat-sen University, Guanzhou, Guangdong, China
• Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
• Hebei Maternity and Reproductive hospital, Shijiazhuang, Hebei, China
• The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
• The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• Reproductive & Genetic Hospital of Citic-Xiangya, Changsha, Hunan, China
• Jinling Hospital,Nanjing University,School Medicine, Nanjing, Jiangsu, China
• Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
• West China Second Hospital of Sichuan University, Chengdu, Sichuan, China
• The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
• Peking University Third Hospital, Beijing, China
• The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
• Northwest women's and children's hospital, Xi'an, China

Collaborators

Jinling Hospital, China · Reproductive Medical Center of Hebei Maternity Hospital · Northwest Women's and Children's Hospital, Xi'an, Shaanxi · The First Medical Center of Chinese People's Liberation Army General Hospital · Shengjing Hospital · First Affiliated Hospital, Sun Yat-Sen University · Reproductive & Genetic Hospital of CITIC-Xiangya · Yikon Genomics Company, Ltd · Peking University Shenzhen Hospital · The Second Hospital of Hebei Medical University · West China Second University Hospital · Second Affiliated Hospital of Wenzhou Medical University · Third Affiliated Hospital of Zhengzhou University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Genetic infertility

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNANCT07369362
  To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
  MotilityCount aps
• ENROLLING BY INVITATIONNCT06419127
  Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing
  Gattaca Genomics
• RECRUITINGNANCT06023472
  Microfluidic Chip vs Density Gradient Centrifugation on the Euploidy Rate of Pre-implantation Genetic Testing
  Professor Ernest Hung-Yu Ng
• RECRUITINGNANCT06358547
  Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years
  Rigshospitalet, Denmark
• RECRUITINGNANCT06261671
  Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
  ART Fertility Clinics LLC
• ACTIVE NOT RECRUITINGNANCT04744025
  Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates
  Lawrence Engmann
• RECRUITINGNCT04528498
  Embryo Health Study
  Genomic Prediction Inc.
• RECRUITINGNCT04477863
  Follow-up With Preimplantation Genetic Testing Patients
  Genomic Prediction Inc.

See all trials for Genetic infertility →